Our team brings together expertise in diagnostics, microbiology, MedTech development, biostatistics, clinical study planning and commercialization.
Prof. Dr. Hans-Peter Deigner, Managing Director
HPD brings extensive management experience in molecular diagnostics and MedTech innovation. He has founded and led several biotech ventures, holds numerous patents in diagnostics, and has guided multiple technologies from laboratory development to market launch.
Dr. Oliver Riester
OR is the inventor of the PEARL technology and a microbiologist with deep expertise in electrochemical sensing, algorithm development, and clinical diagnostics.
Prof. Dr. Matthias Kohl
MK is a statistician and data scientist who specializes in biostatistics, algorithm design and clinical study planning. He is manager of the Steinbeis Transfer Center Personalized Medicine and has over 20 years of experience advising students, scientists, and companies on all kinds of statistical issues. He is the author of over 200 peer-reviewed publications and more than 30 extension packages for the statistical software R (h-index > 50).